|
× |
 |
Clozapine in Treatment-Resistant Patients With Schizophrenia, Schizoaffective Disorder, or Psychotic Bipolar Disorder: A Naturalistic 48-Month Follow-Up Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Cyclic Vomiting Syndrome: An Update Illustrated by a Case Report PDF |
$40.00 |
|
$40.00 |
|
× |
|
Intracerebral Hemorrhages Related to Clinical Conditions and Associated Outcomes Among Saudi and Non-Saudi Patients in a University Hospital: A Retrospective Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Effects of Behavioral Therapy on Weight Loss in Overweight and Obese Patients With Schizophrenia or Schizoaffective Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Exposure to Second-Generation Antipsychotics and Risk of Type 2 Diabetes Mellitus in Adolescents and Young Adults: A Nationwide Study in Taiwan PDF |
$40.00 |
|
$40.00 |
|
× |
|
Treatment With Rosuvastatin for Severe Dyslipidemia in Patients With Schizophrenia and Schizoaffective Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Comparison of Treatment-Emergent Extrapyramidal Symptoms in Patients With Bipolar Mania or Schizophrenia During Olanzapine Clinical Trials PDF |
$40.00 |
|
$40.00 |
|
× |
|
Paroxetine CR Augmentation for Posttraumatic Stress Disorder Refractory to Prolonged Exposure Therapy PDF |
$40.00 |
|
$40.00 |
|
× |
|
Pindolol Augmentation of Treatment-Resistant Depressed Patients PDF |
$40.00 |
|
$40.00 |
|
× |
|
Incidence of Tardive Dyskinesia and Tardive Dystonia in African Caribbean Patients on Long-Term Antipsychotic Treatment: The Curaçao Extrapyramidal Syndromes Study V PDF |
$40.00 |
|
$40.00 |
|
× |
|
Suicide Risk Assessment Received Prior to Suicide Death by Veterans Health Administration Patients With a History of Depression PDF |
$40.00 |
|
$40.00 |
|
× |
|
Olanzapine Treatment After Clozapine-Induced Granulocytopenia in 3 Patients PDF |
$40.00 |
|
$40.00 |
|
× |
|
Paroxetine, Other Antidepressants, and Youth Suicide in New York City: 1993 Through 1998 PDF |
$40.00 |
|
$40.00 |
|
× |
|
Aripiprazole-Induced Urinary Incontinence PDF |
$40.00 |
|
$40.00 |
|
|
